Home
About | Stats | Help
Lets Talk MRSA 20 Frequently Asked Questions What is vancomycin 'MIC creep'? In this Episode Dr. George Zhanel from University of Manitoba in Canada provides insights on vancomycin MIC creep the evidence and its implications.

Video Duration: 11:17 Oct 7, 7:00 pm CDT Views: 5 Download Video

Lets Talk MRSA 20 Frequently Asked Questions
Author : Vemco MedEd
Homepage : http://www.vemcomeded.com/
Subscribe : http://vemcomeded.com/mrsa/vmepodcast_3123_20 (RSS 2.0/UTF-8)

Designed to clarify persistent issues in serious MRSA infections that pose a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4 2010.

0

Latest Videos Most Viewed
What is vancomycin MIC creep
Let's Talk MRSA: 20 Frequently



What is communityassociated MRSA How is it differe
Let's Talk MRSA: 20 Frequently



Why is the prevalence of MRSA increasing in the ho
Let's Talk MRSA: 20 Frequently



What are the short and longterm challenges as well
Let's Talk MRSA: 20 Frequently



How can we prevent the spread of MRSA in the hospi
Let's Talk MRSA: 20 Frequently



Is there a role for OPAT in the management of pati
Let's Talk MRSA: 20 Frequently



Can we determine the appropriate duration of thera
Let's Talk MRSA: 20 Frequently



What stewardship tactics can be applied to the man
Let's Talk MRSA: 20 Frequently



Can we differentiate among newer agents for MRSA b
Let's Talk MRSA: 20 Frequently



How should clinicians manage MRSA bacteremia and i
Let's Talk MRSA: 20 Frequently



How can primary care physicians manage communityas
Let's Talk MRSA: 20 Frequently



What is the optimal treatment for MRSA nosocomial
Let's Talk MRSA: 20 Frequently



What are the therapeutic options for a complicated
Let's Talk MRSA: 20 Frequently



How can clinicians optimally manage communityassoc
Let's Talk MRSA: 20 Frequently



What strategies can be used to effectively manage
Let's Talk MRSA: 20 Frequently



When should an alternative agent to vancomycin be
Let's Talk MRSA: 20 Frequently



What are the toxicity concerns associated with usi
Let's Talk MRSA: 20 Frequently



Should therapeutic drug monitoring be considered w
Let's Talk MRSA: 20 Frequently



What is the appropriate vancomycin dosing to maxim
Let's Talk MRSA: 20 Frequently



Why is MRSA such a problematic pathogen
Let's Talk MRSA: 20 Frequently